<b>Conclusions:</b> By focusing on CD8_EM T cells shared by MDD and ovarian cancer, we identified CLSTN3 as a candidate molecule through nominated by the convergence of genetic, transcriptomic, and functional evidence. This evidence concerns the gene CLSTN3 and ovarian carcinoma.